EP1429739A1
(en)
|
2001-09-21 |
2004-06-23 |
Egalet A/S |
Polymer release system
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
DE602004031096D1
(en)
|
2003-03-26 |
2011-03-03 |
Egalet As |
MORPHINE SYSTEM WITH CONTROLLED RELEASE
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004032051A1
(en)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Process for the preparation of a secured against misuse, solid dosage form
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE10336400A1
(en)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Anti-abuse dosage form
|
DE102005005446A1
(en)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Break-resistant dosage forms with sustained release
|
DE10361596A1
(en)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Process for producing an anti-abuse dosage form
|
DE102004032049A1
(en)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Anti-abuse, oral dosage form
|
DE102005005449A1
(en)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Process for producing an anti-abuse dosage form
|
SA07280459B1
(en)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic
|
DE102007011485A1
(en)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Dosage form with more difficult abuse
|
AU2008258596B2
(en)
|
2007-06-04 |
2013-02-14 |
Egalet Ltd |
Controlled release pharmaceutical compositions for prolonged effect
|
BRPI0906467C1
(en)
|
2008-01-25 |
2021-05-25 |
Gruenenthal Gmbh |
pharmaceutical dosage form with modified tear-resistant outer shape and controlled release
|
LT2273983T
(en)
|
2008-05-09 |
2016-10-25 |
Grünenthal GmbH |
Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
|
NZ594207A
(en)
|
2009-02-06 |
2013-03-28 |
Egalet Ltd |
Immediate release composition resistant to abuse by intake of alcohol
|
AU2010265213B2
(en)
|
2009-06-24 |
2012-08-23 |
Egalet Ltd. |
Controlled release formulations
|
EP2456427B1
(en)
|
2009-07-22 |
2015-03-04 |
Grünenthal GmbH |
Hot-melt extruded controlled release dosage form
|
AU2010275754B2
(en)
|
2009-07-22 |
2014-05-15 |
Grünenthal GmbH |
Tamper-resistant dosage form for oxidation-sensitive opioids
|
WO2011095314A2
(en)
|
2010-02-03 |
2011-08-11 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
EP2366378A1
(en)
|
2010-03-01 |
2011-09-21 |
Dexcel Pharma Technologies Ltd. |
Sustained-release donepezil formulations
|
MX2013002293A
(en)
|
2010-09-02 |
2013-05-09 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising an anionic polymer.
|
WO2012028319A1
(en)
|
2010-09-02 |
2012-03-08 |
Grünenthal GmbH |
Tamper resistant dosage form comprising inorganic salt
|
KR20130097201A
(en)
|
2010-09-02 |
2013-09-02 |
그뤼넨탈 게엠베하 |
Tamper resistant dosage form comprising an anionic polymer
|
LT2736497T
(en)
|
2011-07-29 |
2017-11-10 |
Grünenthal GmbH |
Tamper-resistant tablet providing immediate drug release
|
BR112014002022A2
(en)
|
2011-07-29 |
2017-02-21 |
Gruenenthal Gmbh |
tamper-resistant tablet providing immediate drug release
|
PE20141171A1
(en)
|
2011-10-06 |
2014-09-21 |
Gruenenthal Chemie |
ORAL PHARMACEUTICAL DOSAGE FORM RESISTANT TO ALTERATION INCLUDING OPIOID AGONIST AND OPIOID ANTAGONIST
|
EA201400590A1
(en)
|
2011-11-17 |
2014-11-28 |
Грюненталь Гмбх |
Resistance to fracture an oral pharmaceutical dosage form comprising a pharmacologically active ingredient opioid antagonist and / or a means, is disgusting, polyalkylene oxide and anionic polymers
|
EP2819657A1
(en)
|
2012-02-28 |
2015-01-07 |
Grünenthal GmbH |
Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
|
US20130225697A1
(en)
|
2012-02-28 |
2013-08-29 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
AU2013248351B2
(en)
|
2012-04-18 |
2018-04-26 |
Grunenthal Gmbh |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
ES2650945T3
(en)
|
2012-05-11 |
2018-01-23 |
Grünenthal GmbH |
Pharmaceutical resistant thermoformed pharmaceutical dosage form containing zinc
|
NZ704011A
(en)
|
2012-07-06 |
2016-04-29 |
Egalet Ltd |
Abuse deterrent pharmaceutical compositions for controlled release
|
JP6466417B2
(en)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
A tamper-resistant dosage form with a bimodal release profile
|
CA2907950A1
(en)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
EA032465B1
(en)
|
2013-07-12 |
2019-05-31 |
Грюненталь Гмбх |
Tamper-resistant oral pharmaceutical dosage form containing ethylene-vinyl acetate polymer and process for the production thereof
|
AU2014356581C1
(en)
|
2013-11-26 |
2020-05-28 |
Grunenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
MX2016007848A
(en)
|
2013-12-16 |
2016-09-07 |
Gruenenthal Gmbh |
Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion.
|
CN106572980A
(en)
|
2014-05-12 |
2017-04-19 |
格吕伦塔尔有限公司 |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
CN106456550A
(en)
|
2014-05-26 |
2017-02-22 |
格吕伦塔尔有限公司 |
Multiparticles safeguarded against ethanolic dose-dumping
|
EP3253376A1
(en)
|
2015-02-03 |
2017-12-13 |
Grünenthal GmbH |
Tamper-resistant dosage form comprising a polyethylene glycol graft copolymer
|
WO2016170094A1
(en)
|
2015-04-24 |
2016-10-27 |
Grünenthal GmbH |
Tamper-resistant fixed dose combination providing fast release of two drugs from particles
|
JP2018513864A
(en)
|
2015-04-24 |
2018-05-31 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
Tamper resistant fixed dose combination resulting in rapid release of two drugs from particles and matrix
|
CA2983640A1
(en)
|
2015-04-24 |
2016-10-27 |
Grunenthal Gmbh |
Tamper-resistant fixed dose combination providing fast release of two drugs from different particles
|
AU2016251854A1
(en)
|
2015-04-24 |
2017-10-19 |
Grunenthal Gmbh |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
JP2018526414A
(en)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
Protection against oral overdose with abuse-inhibiting immediate release formulations
|
US20170296476A1
(en)
|
2016-04-15 |
2017-10-19 |
Grünenthal GmbH |
Modified release abuse deterrent dosage forms
|
CA3029869A1
(en)
|
2016-07-06 |
2018-01-11 |
Grunenthal Gmbh |
Reinforced pharmaceutical dosage form
|
CA3032598A1
(en)
|
2016-08-01 |
2018-02-08 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising an anionic polysaccharide
|
AU2017310006A1
(en)
|
2016-08-12 |
2019-01-31 |
Grünenthal GmbH |
Tamper resistant formulation of ephedrine and its derivatives
|
CN111465390A
(en)
|
2017-10-13 |
2020-07-28 |
格吕伦塔尔有限公司 |
Modified release abuse deterrent dosage forms
|
EP3473246A1
(en)
|
2017-10-19 |
2019-04-24 |
Capsugel Belgium NV |
Immediate release abuse deterrent formulations
|
TW202002957A
(en)
|
2018-02-09 |
2020-01-16 |
德商歌林達有限公司 |
Tamper resistant formulation of ephedrine and its derivatives comprising a conversion inhibitor
|
EP3698776A1
(en)
|
2019-02-19 |
2020-08-26 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
WO2021219576A1
(en)
|
2020-04-27 |
2021-11-04 |
Grünenthal GmbH |
Multiparticulate dosage form containing eva copolymer and additional excipient
|
WO2021219577A1
(en)
|
2020-04-27 |
2021-11-04 |
Grünenthal GmbH |
Dosage form comprising hot-melt extruded pellets containing eva copolymer and gliding agent
|